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Abstract
Background: Honey has been shown to have wound healing properties which can be ascribed to
its antimicrobial activity. The antimicrobial activity can be effective against a broad spectrum of
bacterial species especially those of medical importance. It has also been shown that there is
considerable variation in the antimicrobial potency of different types of honey, which is impossible
to predict. With this in mind we tested the antimicrobial activity of honeys produced from plants
grown in South Africa for their antibacterial properties on selected standard strains of oral micro-
organisms.
Methods: The honeys used were produced from the blossoms of Eucalyptus cladocalyx (Bluegum)
trees, an indigenous South African plant Leucospermum cordifolium (Pincushion), a mixture of wild
heather shrubs, mainly Erica species (Fynbos) and a Leptospermum scoparium (Manuka) honey. Only
pure honey which had not been heated was used. The honeys were tested for their antimicrobial
properties with a broth dilution method.
Results: Although the honeys produced some inhibitory effect on the growth of the micro-
organisms, no exceptionally high activity occurred in the South African honeys. The carbohydrate
concentration plays a key role in the antimicrobial activity of the honeys above 25%. However,
these honeys do contain other antimicrobial properties that are effective against certain bacterial
species at concentrations well below the hypertonic sugar concentration. The yeast C. albicans was
more resistant to the honeys than the bacteria. The species S. anginosus and S. oralis were more
sensitive to the honeys than the other test bacteria.
Conclusion: The honeys produced from indigenous wild flowers from South Africa had no
exceptionally high activity that could afford medical grade status.
Background
The potential of honey to assist with wound healing has
been demonstrated repeatedly [1,2]. It has proven valua-
ble in the treatment of infantile gastroenteritis, infected
surgical wounds, burns, decubitus ulcers, skin crafting and
surgical debridement [2-9]. The healing properties of
honey can be ascribed to the fact that it offers antibacterial
activity, maintains a moist wound environment that pro-
motes healing and has a high viscosity which helps to pro-
vide a protective barrier to prevent infection [10].
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It has been shown that natural unheated honey has some
broad-spectrum antibacterial activity when tested against
pathogenic bacteria, oral bacteria as well as food spoilage
bacteria [10-12]. It is also clear from these studies that
bacteria are not uniformly affected by honey. Further-
more, it has been shown that different honeys vary sub-
stantially in the potency of their antibacterial activity,
which varies with the plant source [10,11,13,14]. At
present a number of honeys are sold with standardized
levels of antibacterial activity. The best known of these is
New Zealand Manuka honey produced from the Manuka
bush, Leptospermum scoparium [14].
The oral streptococci play an important role in oral health.
They are involved in dental plaque development and the
formation of dental caries. Candida albicans is an oppor-
tunistic pathogen of the oral cavity that may cause oral
disease in especially the immune compromised individ-
ual, the elderly and those individuals wearing dentures.
There is evidence that honey with a high antibacterial
activity could be used to reduce dental plaque in the treat-
ment of oral disease [15]. However little information is
available with regards to effect of different honeys on
putative oral pathogens.
The search for other honeys from different sources with
enhanced antibacterial activity continues. South Africa
has a large floral biodiversity with many unique plants
indigenous to the region. Honeys are produced from these
plants and sold commercially in South Africa. However
none of these have been tested for their antimicrobial
activity and possible use as medical grade honey. The aim
of the present study was to investigate the antimicrobial
activity of two South African honeys produced from indig-
enous plants unique to South Africa and two honeys pro-
duced from alien species against selected reference
cultures of potential oral pathogens.
Methods
The honey types used were as follows: a honey produced
from the blossoms of Leucospermum cordifolium, a wild
shrub unique to the Cape Peninsula of South Africa (Pin-
cushion honey); a honey produced from a mixture of
many heather shrubs but mainly from Erica species found
on the southern coastal parts of South Africa (Fynbos
honey); a honey produced from Eucalyptus cladocalyx trees
(Bluegum honey) an alien species originally from Aus-
tralia; a honey locally produced from the L. scoparium
plant (Manuka bush) that was obtained from New Zea-
land. Honey types were identified and their source noted
by the apiarists themselves. Only pure honey which had
not been heated was used. The honeys were stored in the
dark at room temperature. The honeys were tested for
their antimicrobial properties against a control solution
with sugar content similar to that of natural honey. The
control carbohydrate solution contained 39% weight/vol-
ume (w/v) d-fructose, 31% (w/v) d-glucose, 8% (w/v)
maltose, 3% (w/v) sucrose and 19% (w/v) water and was
kept refrigerated when not in use [16].
The minimal inhibitory concentrations (MICs) were
determined with a broth dilution method [17]. A 50%
stock solution of honey and of the sugar control solution
was prepared in double strength sterile Brain Heart Infu-
sion (BHI) broth (Oxoid). Two-fold dilutions of the stock
solutions were aseptically prepared in sterile BHI broth
(Oxoid) using a carry-over technique to give a final vol-
ume of 5 ml in each tube. This was repeated until a dilu-
tion range of 50%, 25%, 12.5%, 6.25% and 3.12% of
honey was obtained. After observing the range in which
inhibition of growth in the honey solutions occurred, a
closer dilution was prepared between dilutions of 25%
and 12.5%.
Phenol was used as a positive control. A 40% stock solu-
tion was prepared in double strength BHI broth from an
80% phenol solution (Merck). Two-fold dilutions of the
40% dilution were aseptically prepared in BHI as
described above.
The inocula used were prepared from overnight growth
cultures in BHI-broth. One hundred microlitre of a 1/100
dilution of the culture was used to inoculate 5 ml of the
test solutions. The tubes were incubated aerobically at 37
degrees C for 24 hours.
In view of the high risk of bacterial contamination from
the environment, each honey sample was tested for steril-
ity beforehand by inoculating 100 ml sterile BHI with 5
ml of the 50% stock solution. Furthermore, each growth
positive tube in the tests was checked microscopically to
confirm that the cell morphology corresponded with the
cell morphology of the inoculum.
The microbial species tested were Streptococcus mutans
(NCTC 10449), Streptococcus salivarius (NCTC 8618),
Streptococcus sanguis (NCTC7864), Streptococcus anginosus
(NCTC 10708), Streptococcus gordonii (NCTC 3165), Strep-
tococcus oralis (NCTC 11427), Streptococcus sobrinus (NCTC
10921),  Candida albicans (NCPF 3118), Escherichia coli
(NCTC 9001) and Staphylococcus aureus (NCTC 8530).
The hydrogen peroxide concentration of each test dilution
was determined one hour after dilution using Peroxid-
Test strips (Merck). The pH of the undiluted honey, as
well as the pH of each dilution was determined with a
glass electrode. All tests were done in triplicate. The honey
solutions were freshly prepared for each assay.BMC Complementary and Alternative Medicine 2008, 8:41 http://www.biomedcentral.com/1472-6882/8/41
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Results
The minimum inhibitory concentrations (MICs) of the
four natural honeys, including the control carbohydrate
solution, are shown in Table 1. No difference was
observed in the antimicrobial activity between the four
honeys for concentrations up to 21%. At these concentra-
tions, honey and the control solution had similar activity
towards all organisms except for two streptococcus spe-
cies. Both S. anginosus and S. oralis were inhibited by the
honeys at concentrations of 17% and 12.5% respectively
but grew up to a carbohydrate concentration of 21% (MIC
25%). At concentrations of 25%, the honeys and the con-
trol solution had variable activity towards the organisms
tested. Bluegum, Pincushion and Manuka honey inhib-
ited the growth of all test bacteria, but not the yeast. How-
ever, E. coli and S. salivarius grew in the Fynbos honey at
this concentration. The carbohydrate control solution
could not inhibit growth of S mutans, S. salivarius, E. coli
and C. albicans at a concentration of 25%. No growth was
observed at concentrations of 50% for the carbohydrate
control or for the honeys tested.
Hydrogen peroxide was detected only at dilutions of
6.25% and 3.12%, at a low concentration of 1 mg/liter.
The pH of the undiluted natural honeys was in the order
of ± 3.6. On dilution with the growth medium, the pH of
each of the dilutions increased from ± 5.25 for the 50%
dilution to ± 7.26 for the 3.12% dilution (Table 2).
Discussion
Our study clearly shows that honeys produced from two
indigenous South African flowers, the endemic L. cordifo-
lium (Pincushion) and Erica spp. (Fynbos) do not have
any exceptionally high broad-spectrum antimicrobial
activity. Furthermore, these honeys were not any different
from two alien species grown in South Africa. In previous
studies, very similar results were obtained with E. cladoca-
lyx (Bluegum) honey [12,18]. These honeys are commer-
cially produced on a large scale and are easily obtainable
off the shelf. However, on a very small scale, honeys are
produced from other floral sources. Considering the large
floral biodiversity in South Africa, a survey of these rare
honeys might uncover a honey with high levels of antimi-
crobial activity.
The poor activity of Manuka honey was disappointing as
previous reports have shown that Manuka honey may
have a very high antimicrobial activity against a number
of bacteria [13,19]. However, not all Manuka honey
exhibits antibacterial activity. High antimicrobial activity
is recorded only in Manuka honey produced from specific
localities, in particular, the East Cape region of the North
Island of New Zealand [20].
The results from this report confirm that honeys from dif-
ferent countries and regions have a wide variability in
their antimicrobial activity. It has been shown that the
antimicrobial activity of honey may range from concen-
trations lower than 3% to concentrations of 50% and
higher [10,13,19]. The honeys we tested had antimicro-
bial activity in the 17 – 25% range against the organisms
that were tested except for S. oralis which showed sensitiv-
ity at 12.5%. The bacteria S. aureus and E. coli, which were
included as reference cultures to previous reports, were
both inhibited in the 50 – 25% range. These species have
been shown to be sensitive at concentrations as low 1.8 –
11% for some honeys [13,21]. This indicates that our
honeys were of a poor antimicrobial quality.
Honey may inhibit bacterial growth due to a number of
different reasons. High sugar concentration (reduced
water activity), low pH, hydrogen peroxide generation,
proteinaceous compounds or other unidentified compo-
nents present in the honey may all provide antimicrobial
activity [11]. Low pH can be ruled out in this study
because the average pH of the honey samples at 21% was
6.47 which falls within the growth range of the micro-
organisms. Although hydrogen peroxide was produced in
our study, it only occurred at the very low dilutions and at
concentrations of ± 1 mg/litre. These concentrations are
Table 1: Minimum inhibitory concentrations (%) of different honeys towards standard strains of oral micro-organisms











S. mutans (10449) 25 25 25 25 50 <2.5
S. salivarius (8618) 25 50 25 25 50 <2.5
S. sanguis (7864) 25 25 25 25 25 <2.5
S. anginosus 
(10708)
17 17 17 17 25 <2.5
S. gordonii (3165) 25 25 25 25 25 <2.5
S. oralis (11427) 12.5 12.5 12.5 12.5 25 <2.5
S. sobrinus (10921) 25 25 25 25 25 <2.5
C. albicans (3118) 50 50 50 50 50 <2.5
E. coli (9001) 25 50 25 25 50 <2.5
S. aureus (8530) 25 25 25 25 25 <2.5BMC Complementary and Alternative Medicine 2008, 8:41 http://www.biomedcentral.com/1472-6882/8/41
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too low to have any bacteriostatic effect. Concentrations
of at least 10 mg/litre are required to inhibit bacterial
growth [22]. It is however possible that the hydrogen per-
oxide production was not at its peak at the time of testing.
It has been shown that hydrogen peroxide production can
peak at different times for different honeys. Some may
take as long as 24 hours [23]. If bacteriostatic concentra-
tions were obtained within the 24 hour incubation
period, lower MICs would probably have been attained.
The honey MICs were very similar to the carbohydrate
control solution which suggests that the main inhibitory
effect was probably as a result of the reduced water activ-
ity, the only exceptions being the bacteria S. anginosis and
S. oralis. Both these strains were sensitive to honey at con-
centrations lower than that observed for the carbohydrate
control, indicating that an unidentified component, that
is active against these organisms, may be present in the
honey.
Conclusion
We conclude that the honeys produced from the two
endemic wildflower plants from South Africa do not differ
from the alien species tested and show no exceptionally
high antimicrobial activity that could provide medical
grade status.
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Table 2: pH of the different honey solutions at each dilution
Honey type Dilution
50% 25% 21% 17% 12.50% 6.25% 3.12%
E. cladocalyx (Bluegum) 5.25 6.41 6.47 6.69 7.10 7.20 7.28
Erica species (Fynbos) 5.19 6.28 6.39 6.54 6.71 6.96 7.15
L. cordifolium (Pincushion) 5.23 6.40 6.52 6.70 6.90 7.30 7.38
L. scoparium (Manuka) 5.17 6.30 6.45 6.64 6.89 7.18 7.30